| 5764 |
Follow up sputum examination for Isoniazid [H] Mono/Poly DR-TB Regimen |
23/01/2024 |
|
| 5765 |
Follow up sputum examination for Longer Oral M/XDR-TB DR-TB Regimen |
23/01/2024 |
|
| 5769 |
Eligibility Criteria for H Mono/poly DR-TB Regimen |
23/01/2024 |
|
| 1597 |
Developing ACSM Annual Action Plan |
23/01/2024 |
Advocacy communication and social mobilization |
| 946 |
Communication channels |
23/01/2024 |
Advocacy communication and social mobilization |
| 949 |
ACSM activities at different levels |
23/01/2024 |
Advocacy communication and social mobilization |
| 5773 |
Pre-treatment Evaluation of TB patients |
23/01/2024 |
|
| 5816 |
Why build content on MTS |
28/01/2024 |
|
| 5829 |
Definitive Treatment Outcomes in NTEP |
29/01/2024 |
|
| 5717 |
How NTEP can support Private Practitioners/Hospitals in TB testing and diagnostic services |
23/02/2024 |
|
| 5719 |
How NTEP can support Private Practitioners/Hospitals in Public Health Actions |
23/02/2024 |
|
| 5720 |
How NTEP can support Private Practitioners/Hospitals in TB Prevention and care |
23/02/2024 |
|
| 5718 |
How NTEP can support Private Practitioners/Hospitals in TB Treatment Services |
23/02/2024 |
|
| 3261 |
Co-trimoxazole prophylactic therapy in persons with HIV and TB coinfection |
26/02/2024 |
TB Comorbidities and special conditions |
| 5837 |
Fast Tracking |
06/03/2024 |
|
| 5847 |
TB prevalence survey insight |
08/03/2024 |
|
| 5849 |
National Multi sectoral action framework |
08/03/2024 |
|
| 5851 |
Objectives of TB Free Workplace |
08/03/2024 |
|
| 1324 |
Classification of TB Laboratories |
09/03/2024 |
Laboratory services and management |
| 5862 |
Awareness generation and Branding |
13/03/2024 |
|
| 5864 |
PPM |
15/03/2024 |
|
| 1631 |
Concept and objectives of supervision |
17/03/2024 |
Surveillance, SM&E and Epidemiology |
| 3309 |
Deduplication while enrolling a new patient |
17/03/2024 |
Ni-kshay, Information Systems and DBT |
| 1832 |
Designated Microscopy Centre [DMC] |
19/03/2024 |
Laboratory services and management |
| 5850 |
Screening for TB in the Workplace |
20/03/2024 |
|
| 5874 |
Fundamental attributes of a program |
27/03/2024 |
|
| 5876 |
Program Structure and programmatic definitions |
27/03/2024 |
|
| 5878 |
NTEP TB Index - Indicators |
27/03/2024 |
|
| 5326 |
Difference between Supervision, Monitoring and Evaluation |
27/03/2024 |
Surveillance, SM&E and Epidemiology |
| 5881 |
Types of Programmatic Data |
27/03/2024 |
|
